Please Wait.....
Report
Respiratory Inhaler Devices Market By Product (Metered dose inhalers, Dry powder inhalers, Soft mist inhalers), By Application (Asthma, Chronic obstructive pulmonary disease, Others), By Distribution Channel (Hospitals pharmacies, Drug store and retail pharmacies, Online providers): Global Opportunity Analysis and Industry Forecast, 2025-2034
Market Report I 2025-10-01 I 310 Pages I Allied Market Research
The respiratory inhaler devices market was valued at $32,421.86 million in 2024 and is estimated to reach $51,868.34 million by 2034, exhibiting a CAGR of 4.8% from 2025 to 2034.
Respiratory inhaler devices are essential medical tools used to deliver medications directly into the lungs for the treatment and management of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders. These devices, including metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers, play a significant role in ensuring targeted drug delivery, rapid symptom relief, and improved patient compliance. Rise in global prevalence of respiratory diseases, driven by increase in air pollution, urbanization, and lifestyle changes, continues to boost demand for advanced inhalation therapies.
Rise in incidence of asthma and COPD across both developed and emerging economies drives the growth of the respiratory inhaler devices market. According to the World Health Organization (WHO), hundreds of millions of people worldwide suffer from chronic respiratory conditions, creating substantial need for efficient inhalation solutions. Technological advancements such as smart inhalers integrated with sensors, digital dose counters, and Bluetooth connectivity are enhancing treatment adherence and monitoring capabilities. In addition, rise in geriatric population and increase in healthcare awareness fuel the adoption of portable, easy-to-use inhaler systems. Pharmaceutical companies focus on developing combination therapies and environmentally friendly propellants further accelerates market expansion.
However, high device costs, coupled with strict regulatory approvals and product recall risks, pose challenges to market growth. Misuse of inhaler devices and lack of patient education regarding proper inhalation techniques lead to suboptimal treatment outcomes, limiting therapeutic effectiveness. Moreover, the shift toward alternative drug delivery routes and the availability of generic products restrain market profitability for premium inhaler manufacturers.
On the other hand, surge in focus on personalized medicine and integration of digital health technologies present significant growth opportunities for market expansion. The development of eco-friendly, propellant-free inhalers and reusable devices aligns with global sustainability goals and emerging green healthcare initiatives. Expansion of healthcare infrastructure in emerging markets such as Asia-Pacific, Latin America, and the Middle East offers untapped potential for inhaler device manufacturers. Furthermore, strategic collaborations between pharmaceutical and medical device companies to introduce AI-enabled inhalers and real-time adherence tracking solutions are expected to redefine patient care and drive the next phase of innovation in the respiratory inhaler devices market. For instance, in 2022, AstraZeneca plc collaborated with Honeywell to transition pMDI inhalers to a next-generation, near-zero GWP propellant; and continued regulatory progress and product updates through 2024 2025.
Segment Review
The respiratory inhaler devices market is segmented into product, application, distribution channel, and region. By product, the market is categorized into metered dose inhalers, dry powder inhalers, and soft mist inhaler. On the basis of application, it is segregated into asthma, chronic obstructive pulmonary disease, and others. On the basis of distribution channel, the market is categorized into hospital pharmacies, drug store & retail pharmacies, and online providers. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Key Findings
On the basis of product, the metered-dose inhalers segment accounted for the largest share in 2024.
On the basis of application, the asthma segment dominated the market in 2024.
On the basis of distribution channel, the drug stores & retail pharmacies segment accounted for the largest share in 2024.
Region-wise, North America held the largest market share in 2024.
Competition Analysis
Major key players that operate in the global respiratory inhaler devices market are AstraZeneca plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis AG, Cipla Ltd, Chiesi Farmaceutici S.p.A., Zydus Lifesciences Limited, Lupin, GlaxoSmithKline Plc, and Sun Pharmaceuticals Industries Ltd.
Additional benefits you will get with this purchase are:
Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis
Key Market Segments By Product Metered dose inhalers
Dry powder inhalers
Soft mist inhalers
By Application Asthma
Chronic obstructive pulmonary disease
Others
By Distribution Channel Hospitals pharmacies
Drug store and retail pharmacies
Online providers
By Region North America U.S.
Canada
Mexico
Europe Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Boehringer Ingelheim International GmbH
Novartis AG
Chiesi Farmaceutici S.p.A.
Lupin
GlaxoSmithKline Plc.
AstraZeneca plc
Teva Pharmaceutical Industries Ltd.
Cipla Ltd.
Zydus Lifesciences Limited
Sun Pharmaceuticals Industries Ltd
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rising Prevalence of Asthma and Chronic Obstructive Pulmonary Disease (COPD)
3.4.1.2. Technological Advancements in Inhaler Design and Drug Delivery Systems
3.4.1.3. Increasing Adoption of Homecare and Self-Administered Therapies
3.4.2. Restraints
3.4.2.1. High Cost of Advanced Inhaler Devices and Limited Access in Low-Income Regions
3.4.3. Opportunities
3.4.3.1. Integration of Smart Inhalers and Digital Health Technologies
CHAPTER 4: RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Metered dose inhalers
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Dry powder inhalers
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Soft mist inhalers
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Asthma
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Chronic obstructive pulmonary disease
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals pharmacies
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Drug store and retail pharmacies
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Online providers
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: RESPIRATORY INHALER DEVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by Distribution Channel
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product
7.2.5.1.2. Market size and forecast, by Application
7.2.5.1.3. Market size and forecast, by Distribution Channel
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product
7.2.5.2.2. Market size and forecast, by Application
7.2.5.2.3. Market size and forecast, by Distribution Channel
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product
7.2.5.3.2. Market size and forecast, by Application
7.2.5.3.3. Market size and forecast, by Distribution Channel
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by Distribution Channel
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product
7.3.5.1.2. Market size and forecast, by Application
7.3.5.1.3. Market size and forecast, by Distribution Channel
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Product
7.3.5.2.2. Market size and forecast, by Application
7.3.5.2.3. Market size and forecast, by Distribution Channel
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Product
7.3.5.3.2. Market size and forecast, by Application
7.3.5.3.3. Market size and forecast, by Distribution Channel
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Product
7.3.5.4.2. Market size and forecast, by Application
7.3.5.4.3. Market size and forecast, by Distribution Channel
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Product
7.3.5.5.2. Market size and forecast, by Application
7.3.5.5.3. Market size and forecast, by Distribution Channel
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product
7.3.5.6.2. Market size and forecast, by Application
7.3.5.6.3. Market size and forecast, by Distribution Channel
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by Distribution Channel
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Product
7.4.5.1.2. Market size and forecast, by Application
7.4.5.1.3. Market size and forecast, by Distribution Channel
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Product
7.4.5.2.2. Market size and forecast, by Application
7.4.5.2.3. Market size and forecast, by Distribution Channel
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Product
7.4.5.3.2. Market size and forecast, by Application
7.4.5.3.3. Market size and forecast, by Distribution Channel
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Product
7.4.5.4.2. Market size and forecast, by Application
7.4.5.4.3. Market size and forecast, by Distribution Channel
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Product
7.4.5.5.2. Market size and forecast, by Application
7.4.5.5.3. Market size and forecast, by Distribution Channel
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product
7.4.5.6.2. Market size and forecast, by Application
7.4.5.6.3. Market size and forecast, by Distribution Channel
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by Distribution Channel
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product
7.5.5.1.2. Market size and forecast, by Application
7.5.5.1.3. Market size and forecast, by Distribution Channel
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Product
7.5.5.2.2. Market size and forecast, by Application
7.5.5.2.3. Market size and forecast, by Distribution Channel
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Product
7.5.5.3.2. Market size and forecast, by Application
7.5.5.3.3. Market size and forecast, by Distribution Channel
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Product
7.5.5.4.2. Market size and forecast, by Application
7.5.5.4.3. Market size and forecast, by Distribution Channel
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2024
CHAPTER 9: COMPANY PROFILES
9.1. AstraZeneca plc
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Boehringer Ingelheim International GmbH
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Teva Pharmaceutical Industries Ltd.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Novartis AG
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. Cipla Ltd.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Chiesi Farmaceutici S.p.A.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Zydus Lifesciences Limited
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. Lupin
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. GlaxoSmithKline Plc.
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Sun Pharmaceuticals Industries Ltd
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
LIST OF TABLES
TABLE 01. GLOBAL RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 02. RESPIRATORY INHALER DEVICES MARKET FOR METERED DOSE INHALERS, BY REGION, 2024-2034 ($MILLION)
TABLE 03. RESPIRATORY INHALER DEVICES MARKET FOR DRY POWDER INHALERS, BY REGION, 2024-2034 ($MILLION)
TABLE 04. RESPIRATORY INHALER DEVICES MARKET FOR SOFT MIST INHALERS, BY REGION, 2024-2034 ($MILLION)
TABLE 05. GLOBAL RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 06. RESPIRATORY INHALER DEVICES MARKET FOR ASTHMA, BY REGION, 2024-2034 ($MILLION)
TABLE 07. RESPIRATORY INHALER DEVICES MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2024-2034 ($MILLION)
TABLE 08. RESPIRATORY INHALER DEVICES MARKET FOR OTHERS, BY REGION, 2024-2034 ($MILLION)
TABLE 09. GLOBAL RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 10. RESPIRATORY INHALER DEVICES MARKET FOR HOSPITALS PHARMACIES, BY REGION, 2024-2034 ($MILLION)
TABLE 11. RESPIRATORY INHALER DEVICES MARKET FOR DRUG STORE AND RETAIL PHARMACIES, BY REGION, 2024-2034 ($MILLION)
TABLE 12. RESPIRATORY INHALER DEVICES MARKET FOR ONLINE PROVIDERS, BY REGION, 2024-2034 ($MILLION)
TABLE 13. RESPIRATORY INHALER DEVICES MARKET, BY REGION, 2024-2034 ($MILLION)
TABLE 14. NORTH AMERICA RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 15. NORTH AMERICA RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 16. NORTH AMERICA RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 17. NORTH AMERICA RESPIRATORY INHALER DEVICES MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 18. U.S. RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 19. U.S. RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 20. U.S. RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 21. CANADA RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 22. CANADA RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 23. CANADA RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 24. MEXICO RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 25. MEXICO RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 26. MEXICO RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 27. EUROPE RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 28. EUROPE RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 29. EUROPE RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 30. EUROPE RESPIRATORY INHALER DEVICES MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 31. GERMANY RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 32. GERMANY RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 33. GERMANY RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 34. FRANCE RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 35. FRANCE RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 36. FRANCE RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 37. UK RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 38. UK RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 39. UK RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 40. ITALY RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 41. ITALY RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 42. ITALY RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 43. SPAIN RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 44. SPAIN RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 45. SPAIN RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 46. REST OF EUROPE RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 47. REST OF EUROPE RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 48. REST OF EUROPE RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 49. ASIA-PACIFIC RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 50. ASIA-PACIFIC RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 51. ASIA-PACIFIC RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 52. ASIA-PACIFIC RESPIRATORY INHALER DEVICES MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 53. JAPAN RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 54. JAPAN RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 55. JAPAN RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 56. CHINA RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 57. CHINA RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 58. CHINA RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 59. INDIA RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 60. INDIA RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 61. INDIA RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 62. AUSTRALIA RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 63. AUSTRALIA RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 64. AUSTRALIA RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 65. SOUTH KOREA RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 66. SOUTH KOREA RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 67. SOUTH KOREA RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 71. LAMEA RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 72. LAMEA RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 73. LAMEA RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 74. LAMEA RESPIRATORY INHALER DEVICES MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 75. BRAZIL RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 76. BRAZIL RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 77. BRAZIL RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 78. SAUDI ARABIA RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 79. SAUDI ARABIA RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 80. SAUDI ARABIA RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 81. SOUTH AFRICA RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 82. SOUTH AFRICA RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 83. SOUTH AFRICA RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 84. REST OF LAMEA RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024-2034 ($MILLION)
TABLE 85. REST OF LAMEA RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 86. REST OF LAMEA RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 87. ASTRAZENECA PLC: KEY EXECUTIVES
TABLE 88. ASTRAZENECA PLC: COMPANY SNAPSHOT
TABLE 89. ASTRAZENECA PLC: PRODUCT SEGMENTS
TABLE 90. ASTRAZENECA PLC: PRODUCT PORTFOLIO
TABLE 91. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY EXECUTIVES
TABLE 92. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT
TABLE 93. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT SEGMENTS
TABLE 94. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT PORTFOLIO
TABLE 95. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY EXECUTIVES
TABLE 96. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
TABLE 97. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT SEGMENTS
TABLE 98. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
TABLE 99. NOVARTIS AG: KEY EXECUTIVES
TABLE 100. NOVARTIS AG: COMPANY SNAPSHOT
TABLE 101. NOVARTIS AG: PRODUCT SEGMENTS
TABLE 102. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 103. CIPLA LTD.: KEY EXECUTIVES
TABLE 104. CIPLA LTD.: COMPANY SNAPSHOT
TABLE 105. CIPLA LTD.: PRODUCT SEGMENTS
TABLE 106. CIPLA LTD.: PRODUCT PORTFOLIO
TABLE 107. CHIESI FARMACEUTICI S.P.A.: KEY EXECUTIVES
TABLE 108. CHIESI FARMACEUTICI S.P.A.: COMPANY SNAPSHOT
TABLE 109. CHIESI FARMACEUTICI S.P.A.: PRODUCT SEGMENTS
TABLE 110. CHIESI FARMACEUTICI S.P.A.: PRODUCT PORTFOLIO
TABLE 111. ZYDUS LIFESCIENCES LIMITED: KEY EXECUTIVES
TABLE 112. ZYDUS LIFESCIENCES LIMITED: COMPANY SNAPSHOT
TABLE 113. ZYDUS LIFESCIENCES LIMITED: PRODUCT SEGMENTS
TABLE 114. ZYDUS LIFESCIENCES LIMITED: PRODUCT PORTFOLIO
TABLE 115. LUPIN: KEY EXECUTIVES
TABLE 116. LUPIN: COMPANY SNAPSHOT
TABLE 117. LUPIN: PRODUCT SEGMENTS
TABLE 118. LUPIN: PRODUCT PORTFOLIO
TABLE 119. GLAXOSMITHKLINE PLC.: KEY EXECUTIVES
TABLE 120. GLAXOSMITHKLINE PLC.: COMPANY SNAPSHOT
TABLE 121. GLAXOSMITHKLINE PLC.: PRODUCT SEGMENTS
TABLE 122. GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
TABLE 123. SUN PHARMACEUTICALS INDUSTRIES LTD: KEY EXECUTIVES
TABLE 124. SUN PHARMACEUTICALS INDUSTRIES LTD: COMPANY SNAPSHOT
TABLE 125. SUN PHARMACEUTICALS INDUSTRIES LTD: PRODUCT SEGMENTS
TABLE 126. SUN PHARMACEUTICALS INDUSTRIES LTD: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. RESPIRATORY INHALER DEVICES MARKET, 2024-2034
FIGURE 02. SEGMENTATION OF RESPIRATORY INHALER DEVICES MARKET,2024-2034
FIGURE 03. TOP IMPACTING FACTORS IN RESPIRATORY INHALER DEVICES MARKET (2024 TO 2034)
FIGURE 04. TOP INVESTMENT POCKETS IN RESPIRATORY INHALER DEVICES MARKET (2025-2034)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL RESPIRATORY INHALER DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. RESPIRATORY INHALER DEVICES MARKET, BY PRODUCT, 2024 AND 2034(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF RESPIRATORY INHALER DEVICES MARKET FOR METERED DOSE INHALERS, BY COUNTRY 2024 AND 2034(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF RESPIRATORY INHALER DEVICES MARKET FOR DRY POWDER INHALERS, BY COUNTRY 2024 AND 2034(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF RESPIRATORY INHALER DEVICES MARKET FOR SOFT MIST INHALERS, BY COUNTRY 2024 AND 2034(%)
FIGURE 15. RESPIRATORY INHALER DEVICES MARKET, BY APPLICATION, 2024 AND 2034(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF RESPIRATORY INHALER DEVICES MARKET FOR ASTHMA, BY COUNTRY 2024 AND 2034(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF RESPIRATORY INHALER DEVICES MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY 2024 AND 2034(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF RESPIRATORY INHALER DEVICES MARKET FOR OTHERS, BY COUNTRY 2024 AND 2034(%)
FIGURE 19. RESPIRATORY INHALER DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 AND 2034(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF RESPIRATORY INHALER DEVICES MARKET FOR HOSPITALS PHARMACIES, BY COUNTRY 2024 AND 2034(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF RESPIRATORY INHALER DEVICES MARKET FOR DRUG STORE AND RETAIL PHARMACIES, BY COUNTRY 2024 AND 2034(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF RESPIRATORY INHALER DEVICES MARKET FOR ONLINE PROVIDERS, BY COUNTRY 2024 AND 2034(%)
FIGURE 23. RESPIRATORY INHALER DEVICES MARKET BY REGION, 2024 AND 2034(%)
FIGURE 24. U.S. RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 25. CANADA RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 26. MEXICO RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 27. GERMANY RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 28. FRANCE RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 29. UK RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 30. ITALY RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 31. SPAIN RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 32. REST OF EUROPE RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 33. JAPAN RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 34. CHINA RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 35. INDIA RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 36. AUSTRALIA RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 37. SOUTH KOREA RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 38. REST OF ASIA-PACIFIC RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 39. BRAZIL RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 40. SAUDI ARABIA RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 41. SOUTH AFRICA RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 42. REST OF LAMEA RESPIRATORY INHALER DEVICES MARKET, 2024-2034 ($MILLION)
FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 44. COMPETITIVE DASHBOARD
FIGURE 45. COMPETITIVE HEATMAP: RESPIRATORY INHALER DEVICES MARKET
FIGURE 46. TOP PLAYER POSITIONING, 2024
FIGURE 47. ASTRAZENECA PLC: NET SALES, 2022-2024 ($MILLION)
FIGURE 48. ASTRAZENECA PLC: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 49. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: NET SALES, 2022-2024 ($MILLION)
FIGURE 50. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 51. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 52. TEVA PHARMACEUTICAL INDUSTRIES LTD.: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 53. TEVA PHARMACEUTICAL INDUSTRIES LTD.: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 54. NOVARTIS AG: NET SALES, 2022-2024 ($MILLION)
FIGURE 55. NOVARTIS AG: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 56. CIPLA LTD.: SALES REVENUE, 2022-2024 ($MILLION)
FIGURE 57. CIPLA LTD.: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 58. CIPLA LTD.: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 59. CHIESI FARMACEUTICI S.P.A.: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 60. CHIESI FARMACEUTICI S.P.A.: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 61. ZYDUS LIFESCIENCES LIMITED: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 62. ZYDUS LIFESCIENCES LIMITED: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 63. ZYDUS LIFESCIENCES LIMITED: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 64. LUPIN: NET SALES, 2022-2024 ($MILLION)
FIGURE 65. LUPIN: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 66. LUPIN: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 67. GLAXOSMITHKLINE PLC.: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 68. GLAXOSMITHKLINE PLC.: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 69. SUN PHARMACEUTICALS INDUSTRIES LTD: NET REVENUE, 2022-2024 ($MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security